Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/ temperature-sensitive virus

Journal of Medical Virology

Volumn 79, Issue 11, 2007, Pages 1731-1740

  Shimada, Yuka ^a   Suzuki, Mikiko ^b   Shirasaki, Fumiaki ^a   Saito, Eriko ^a   Sogo, Kana ^a   Hasegawa, Minora ^a   Takehara, Kazuhiko ^a   Phromjai, Jurairatana ^b   Chuhjo, Tatsuya ^a   Shiraki, Kimiyasu ^b  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Acyclovir; Herpes simplex virus; Pathogenicity; Reactivation; Temperature sensitive; Thymidine kinase deficient

Indexed keywords

ACICLOVIR; ANTINEOPLASTIC AGENT; CYCLOSPORIN; FOSCARNET; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISOLONE ACETATE; RETINOIC ACID; TACROLIMUS; THYMIDINE KINASE; VALACICLOVIR; VIDARABINE; VIRUS DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASE REPORT; CONTROLLED STUDY; DISEASE COURSE; DNA ISOLATION; ENZYME ACTIVITY; FEMALE; GENITAL ULCER; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RESTRICTION MAPPING; TEMPERATURE SENSITIVE MUTANT; VIRUS GENE; VIRUS ISOLATION; VIRUS MUTATION; VIRUS REACTIVATION; VIRUS VIRULENCE;

ACYCLOVIR; ADULT; ANIMALS; ANTIVIRAL AGENTS; EAR; FEMALE; FINGERS; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RECURRENCE; SEQUENCE ANALYSIS, DNA; TEMPERATURE; THYMIDINE KINASE; VIRUS ACTIVATION;

HERPES; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 34748855127     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20990     Document Type: Article

References (48)

1. Aldea C, Alvarez CP, Folgueira L, Delgado R, Otero JR. 2002. Rapid detection of herpes simplex virus DNA in genital ulcers by real-time PCR using SYBR green I dye as the detection signal. J Clin Microbiol 40:1060-1062.
2. Balfour HH, Jr. 1983. Resistance of herpes simplex to ACV. Ann Intern Med 98:404-406.
3. Balfour HH, Jr., Benson C, Braun J, Cassens B, Erice A, Friedman-Kien A, Klein T, Polsky B, Safrin S. 1994. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. J Acq Immun Def Synd 7:254-260.
4. Bast DJ, Yue M, Chen X, Bell D, Dresser L, Saskin R, Mandell LA, Low DE, de Azavedo JCS. 2004. Novel murine model of pneumococcal pneumonia: Use of temperature as a measure of disease severity to compare the efficacies of moxifloxacin and lovofloxacin. Antimicrob Agents Chemother 48:3343-3348.
5. Buchman TG, Roizman B, Adams G, Stover BH. 1978. Restriction endonuclease fingerprinting of herpes simplex virus DNA: A novel epidemiological tool applied to a nosocomial outbreak. J Infect Dis 138:488-498.
6. Buchman TG, Simpson T, Nosal C, Roizman B, Nahmias AJ. 1980. The structure of herpes simplex virus DNA and its application to molecular epidemiology. Ann NY Acad Sci 354:279-290.
7. Burns WH, Saral R, Santos GW, Laskin OL, Lietman PS, McLaren C, Barry DW. 1982. Isolation and characterization of resistant herpes simplex virus after ACV therapy. Lancet 1:421-423.
8. Chakrabarti S, Pillay D, Ratcliffe D, Cane PA, Collingham KE, Milligan DW. 2000. Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: Risk factors and prognostic significance. J Infect Dis 181:2055-2058.
9. Chen Y, Scieux C, Garrait V, Socie G, Rocha V, Molina JM, Thouvenot D, Morfin F, Hocqueloux L, Garderet L, Esperou H, Selimi F, Devergie A, Leleu G, Aymard M, Morinet F, Gluckman E, Ribaud P. 2000. Resistant herpes simplex virus type 1 infection: An emerging concern after allogeneic stem cell transplantation. Clin Infect Dis 31:927-935.
10. Crumpacker CS, Schnipper LE, Marlowe SI, Kowalsky PN, Hershey BJ, Levin MJ. 1982. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med 306:343-346.
11. Daanen HAM, Van de Linde FJG, Romet TT, Ducharme MB. 1997. The effect of body temperature on the hunting response of the middle finger skin temperature. Eur J Appl Physiol 76:538-543.
12. Danno K, Sugie N. 1996. Effects of near-infrared radiation on the epidermal proliferation and cutaneous immune function in mice. Photodermatol Photoimmunol Photomed 12:233-236.
13. Elion GB, Furman PA, Fyfe JA, Miranda P, de Beauchamp L, Schaeffer H. 1977. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci USA 74:5716-5720.
14. Erlich KS, Mills J, Chatis P, Mertz GJ, Busch DF, Follansbee SE, Grant RM, Crumpacker CS. 1989. ACV-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med 320:293-296.
15. Field HJ, Darby G. 1980. Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo. Antimicrob Agents Chemother 17:209-216.
16. Gaudreau A, Hill E, Balfour HH, Jr., Erice A, Boivin G. 1998. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis 178:297-303.
17. Gilbert C, Bestman-Smith J, Boivin G. 2002. Resistance of herpes-viruses to antiviral drugs: Clinical impacts and molecular mechanisms. Drug Resist Updat 5:88-114.
18. Grey F, Sowa M, Collins P, Fenton RJ, Harris W, Snowden W, Efstathiou S, Darby G. 2003. Characterization of a neurovirulent aciclovir-resistant variant of herpes simplex virus. J Gen Virol 84: 1403-1410.
19. Griffiths A, Coen DM. 2003. High-frequency phenotypic reversion and pathogenicity of an acyclovir-resistant herpes simplex virus mutant. J Virol 77:2282-2286.
20. Griffiths A, Chen SH, Horsburgh BC, Coen DM. 2003. Translational compensation of a frameshift mutation affecting herpes simplex virus thymidine kinase is sufficient to permit reactivation from latency. J Virol 77:4703-4709.
21. Harris W, Collins P, Fenton RJ, Snowden W, Sowa M, Darby G. 2003. Phenotypic and genotypic characterization of clinical isolates of herpes simplex virus resistant to acyclovir. J Gen Virol 84:1393-1401.
22. Hasegawa T, Kawana T, Okuda T, Horii M, Tsukada T, Shiraki K. 2001. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan. J Med Virol 63:57-63.
23. Honda M, Okuda T, Hasegawa T, Kurokawa M, Shiraki K, Matsuo K, Komatsuzaki M, Niimura M. 2001. Affect of long-term, low-dose acyclovir suppressive therapy on herpes simplex virus type 2 susceptibility to acyclovir and frequency of acyclovir-resistance. Antiviral Chem Chemother 12:243-249.
24. Hwang CB, Horsburgh BC, Pelosi E, Roberts S, Digard P, Coen DM. 1994. A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant. Proc Natl Acad Sci USA 91:5461-5465.
25. Ida M, Kageyama S, Sato H, Kamiyama T, Yamamura J, Kurokawa M, Morohashi M, Shiraki K. 1999. Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants. Antiviral Res 40:155-166.
26. Kaplowitz LG, Baker D, Gelb L, Blythe J, Hale R, Frost P, Crumpacker C, Rabinovich S, Peacock JE Jr., Herndon J, Davis LG. The Acyclovir Study Group. 1991. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. JAMA 265:747-751.
27. Kimura H, Ito Y, Futamura M, Ando Y, Yabuta Y, Hoshino Y, Nishiyama Y, Morishima T. 2002. Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2. J Med Virol 67:349-353.
28. Kost RG, Hill EL, Tigges M, Straus SE. 1993. Recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N Engl J Med 329:1777-1782.
29. Kurokawa K, Ochiai H, Nagasaka K, Neki M, Xu H, Kadota S, Sutardio S, Matsumoto T, Namba T, Shiraki K. 1993. Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice. Antiviral Res 22:175-188.
30. Kurokawa M, Hozumi T, Basnet P, Nakano M, Kadota S, Namba T, Kawana T, Shiraki K. 1998. Purification and characterization of eugeniin as an anti-herpes virus compound from Geum japonicum and syzygium aromaticum. J Pharmacol Exp Therapeut 284:728-735.
31. Morfin F, Souillet G, Bilger K, Ooka T, Aymard M, Thouvenot D. 2000a. Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients. J Infect Dis 182:290-293.
32. Morfin F, Thouvenot D, Aymard M, Souillet G. 2000b. Reactivation of acyclovir-resistant thymidine kinase-deficient herpes simplex virus harbouring single base insertion within a 7 Gs homopolymer repeat of the thymidine kinase gene. J Med Virol 62:247-250.
33. Nagasaka K, Kurokawa M, Imakita M, Terasawa K, Shiraki K. 1995. Efficacy of Kakkon-to, a traditional herb medicine, in herpes simplex virus type 1 infection in mice. J Med Virol 46:28-34.
34. Oerlemans HM, Graff MJ, Dijkstra-Hekkink JB, Boo T, de Goris RJ, Oostendorp RA. 1999. Reliability and normal values for measuring the skin temperature of the hand with an infrared tympanic thermometer: A pilot study. J Hand Ther 12:284-290.
35. Okuda T, Kurokawa K, Matsuo K, Honda M, Niimura M, Shiraki K. 2004. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by its sensitive virus. J Med Virol 72:112-120.
36. Phromjai J, Aiba N, Suzuki M, Sato H, Takahara T, Kondo S, Shiraki K. 2007. Infection and direct injury in human hepatocyte expiants and a hepatoblastoma cell line due to hepatiticomimetic (non-hepatitis) viruses. J Med Virol 79:413-425.
37. Sacks SL, Wanklin RJ, Reece DE, Hicks KA, Tyler KL, Coen DM. 1989. Progressive esophagitis from acyclovir-resistant herpes simplex. Ann Intern Med 111:893-899.
38. Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J, Kessler HA, Landy B, Mills J. Other members of the AIDS Clinical Trials Group. 1991. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N Engl J Med 325:551-555.
39. Saijo M, Yasuda Y, Yabe-Kato S, Suzutani T, De Clercq E, Niikura M, Maeda A, Kurane I, Morikawa S. 2002. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: Emergence of foscarnet-resistant virus originating from the ACV(r) virus. J Med Virol 68:99-104.
40. Sasadeusz JJ, Sacks SL. 1996. Spontaneous reactivation of thymidine kinase-deficient, acyclovir-resistant herpes simplex virus: Masked heterogeneity or reversion. J Infect Dis 174:476-482.
41. Sasadeusz JJ, Tufaro F, Safrin S, Schubert K, Hubinette MM, Cheung PK, Sacks SL. 1997. Homopolymer mutational hot spots mediate herpes simplex virus resistance to ACV. J Virol 71:3872-3878.
42. Shiraki K, Ogino T, Yamanishi K, Takahashi M. 1985. Immunochemical characterization of pyrimidine kinase induced by varicellazoster virus. J Gen Virol 66:221-229.
43. Shiraki K, Horiuchi K, Asano Y, Yamanishi K, Takahashi M. 1991. Differentiation of Oka varicella vaccine strain from wild varicellazoster virus strains isolated from vaccinees and household contact. J Med Virol 33:128-132.
44. Simmons A, Nash AA. 1984. Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J Virol 52:816-821.
45. Swetter SM, Hill EL, Kern ER, Koelle DM, Posavad CM, Lawrence W, Safrin S. 1998. Chronic vulvar ulceration in an immunocompetent woman due to ACV-resistant, thymidine kinase-deficient herpes simplex virus. J Infect Dis 177:543-550.
46. Wade JC, McLaren C, Meyers JD. 1983. Frequency and significance of ACV-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with ACV. J Infect Dis 148:1077-1082.
47. Whitley RJ, Spruance S, Hayden FG, Overall J, Afford CA, Jr, Gwaltney JM, Jr., Soong SJ. 1984. Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised host. J Infect Dis 149:1-8.
48. Yoshida Y, Li ZH, Kurokawa M, Kawana T, Imakita M, Shiraki K. 2005. Growth of herpes simplex virus in epidermal keratinocytes determines cutaneous pathogenicity in mice. J Med Virol 75:421-426.